Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,736 | -11,681 | -24,598 | -25,322 | -18,593 |
| Depreciation Amortization | 180 | 6,223 | 2,092 | 1,172 | 921 |
| Accounts receivable | 115 | 83 | 275 | -296 | -99 |
| Accounts payable and accrued liabilities | -1,703 | -1,259 | 3,284 | 472 | 778 |
| Other Working Capital | -1,201 | -1,911 | 3,204 | 409 | -531 |
| Other Operating Activity | -70 | -3,070 | -871 | 2,209 | 2,584 |
| Operating Cash Flow | $-7,414 | $-11,614 | $-16,614 | $-21,356 | $-14,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | N/A | -682 | -1,227 | -467 |
| Purchase Sale Intangibles | -65 | N/A | -1,000 | N/A | -1,000 |
| Other Investing Activity | -65 | 0 | -1,000 | 0 | -1,000 |
| Investing Cash Flow | $-117 | $N/A | $-1,682 | $-1,227 | $-1,467 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,966 | 5,489 | 4,892 | N/A |
| Debt Repayment | N/A | -10,750 | -4,864 | -137 | N/A |
| Common Stock Issued | 10,812 | 10,434 | 10,950 | 20,120 | 499 |
| Other Financing Activity | 0 | 10,225 | 100 | -500 | 52 |
| Financing Cash Flow | $10,812 | $13,875 | $11,676 | $24,375 | $550 |
| Beginning Cash Position | 3,364 | 1,103 | 7,723 | 5,931 | 21,788 |
| End Cash Position | 6,644 | 3,364 | 1,103 | 7,723 | 5,931 |
| Net Cash Flow | $3,280 | $2,261 | $-6,620 | $1,792 | $-15,857 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,414 | -11,614 | -16,614 | -21,356 | -14,940 |
| Capital Expenditure | -52 | N/A | -682 | -1,227 | -467 |
| Free Cash Flow | -7,466 | -11,614 | -17,295 | -22,583 | -15,407 |